The FOCUS Self-Assessment Examination program is intended to assist psychiatrists in keeping abreast of new knowledge and scientific developments in the field of psychiatry and in maintaining a lifelong learning program that will fulfill the needs of self-assessment and ongoing Maintenance of Certification. The topics for the 2014 Focus program are:
- Disorders of Sleep
- Eating Disorders
The FOCUS examination may also be useful in studying for other examinations, such as the Psychiatry Recertification Examination of the American Board of Psychiatry and Neurology. Note: Although it is anticipated that participation in the FOCUS study and self-assessment examination will be helpful for psychiatrists taking other examinations, no guarantee concerning actual performance on other examinations is intended or implied. The American Board of Psychiatry and Neurology has developed a 10-year MOC program that includes self-assessment. The FOCUS Self-Assessment Examination is a broad-based self-assessment activity approved by the ABPN for this purpose.
Subscription and Pricing
This activity is only available to 2014 Focus subscribers. New subscriptions for 2014 Focus are no longer available for sale.
If you have questions about Focus subscriptions, please contact email@example.com.
At the completion of the activity, participants will:
1. Have an increased understanding of current knowledge and new developments in psychiatric diagnosis and treatment and be able to apply this information to improve patient care;
2. Recognize areas where more study is needed; and
3. Validate current practice or make improvements in professional practice.
This program is one element of a lifelong learning program for physicians and as an aid for psychiatrists studying for recertification.
Estimated Time to Complete
Estimated Duration: 24 hours
Program Release Date: October 1, 2014
Program End Date: October 31, 2017
How to Earn Credit
To earn credit for the FOCUS Self-Assessment, participants complete all questions and the evaluation and review their score. The minimum performance level requirement is fulfilled by answering all questions and by receipt of a score and peer comparison. This activity is designed to identify areas for improvement and further study; credit will be awarded for completion of the self-assessment.
The answers, rationales, and references for further study are provided. We urge that as a minimum, the rationale for each question answered incorrectly be reviewed. Many participants may wish to review the rationales for all of the multiple choice questions. Participants will receive a detailed score report and peer comparison online. The peer comparison is a dynamic report and will change as participation increases. After completing the course, you can then claim and print your CME certificate.
Continuing Education Credit and ABPN Approval Statement
The American Psychiatric Association is accredited by ACCME to provide continuing medical education for physicians. APA designates this enduring material CME activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPN Approval for MOC Part 2 (Self-Assessment)
The American Board of Psychiatry and Neurology strongly supports an organized plan of lifelonglearning for its psychiatric diplomates and reviews specific APA Category 1 CME activities for this purpose. The American Board of Psychiatry and Neurology has reviewed FOCUS: The Journal of Lifelong Learning in Psychiatry and the FOCUS Self-Assessment Examination and has approved this programas part of a comprehensive lifelong learning and self-assessment program, which is mandatedby the ABMS as a necessary component of Maintenance of Certification, Part 2.
APA reports MOC completion data on behalf of our members directly to ABPN, however, diplomates are still required to log on to their ABPN Physician Folios at least once per calendar year to attest to completion of their MOC activities.
Royal College of Physicians and Surgeons of Canada
The Focus Self-Assessment Program (Vol. XII) is an accredited self-assessment program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons ofCanada, and was approved by the Canadian Psychiatric Association on Oct. 1, 2014. This program expiresSept. 30, 2017. Remember to visit MAINPORT (https://www.mainport.org/mainport/) to record your learning and outcomes. You may claim a maximum of 24 hours (credits are automatically calculated).
American Academy of Physician Assistants
This Self-Assessment CME program has been reviewed and is approved for a maximum of 24 AAPA Category 1 Self-Assessment CME credits by the Physician Assistant Review Panel of the American Academy of Physician Assistants. Approval is valid until October 31, 2017. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards.
Faculty and Planner Disclosures
No support from commercial sources was used in the development and production of this CME program.
No financial affiliations with commercial organizations
- Deborah J. Hales, M.D. Director, American Psychiatric Association Division of Education, Arlington, Virginia
- Mark Hyman Rapaport, M.D. Chairman, Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia
- Robert J. Boland, M.D. Vice Chair of Education, Department of Psychiatry, Brigham and Women’s Hospital, Boston, Massachusetts
- Laura Fochtmann, M.D. Professor, Department of Psychiatry and Behavioral Sciences, Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York and Practice Guidelines Medical Editor, American Psychiatric Association
- Annette M. Matthews, M.D. Psychiatrist, Portland Veterans Affairs Medical Center, Portland,Oregon, Associate Professor, Department of Psychiatry and Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon
- Lindsay J. Moskowitz, M.D. Director, Eating Disorders Service, North Shore-Long Island JewishMedical Center, New Hyde Park, NY
- Deepak Prabhakar, M.D., M.P.H. Assistant Professor, Director of Psychiatric Education, TrainingDirector, Psychiatry Residency Program, Henry Ford Hospital/Wayne State University Behavioral HealthServices, Henry Ford Health Systems, Detroit, Michigan
- Brenda Roman, M.D. Assistant Dean for Curriculum Development, Boonshoft School of Medicine, Wright State University, Dayton, Ohio
- Shawn Sidhu, M.D. Assistant Professor, University of New Mexico Department of Psychiatry and Behavioral Psychiatrist, Albuquerque, New Mexico
- Eric R. Williams, M.D. Assistant Professor of Child and Adolescent Psychiatry, University of SouthCarolina School of Medicine, Columbia, South Carolina
Disclosure of Interests
- Arden D. Dingle, M.D. Professor Emeritus, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia | Advisory Board: Amerigroup Behavioral Health Advisory Committee
- James W. Jefferson, M.D. Clinical Professor of Psychiatry, University of Wisconsin School ofMedicine and Public Health, Distinguished Senior Scientist, Madison Institute of Medicine, Inc.,Director, Healthcare Technology Systems, Inc., Madison, Wisconsin | Lecture Honoraria: Arbor Scientica, GlaxoSmithKline, Lilly, Merck, Purdue, Sunovion. Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone. Principal: Healthcare Technology Systems, Inc.
- Vishal Madaan, M.D. Director, Child and Family Psychiatry Clinic, Associate Training Director,General Psychiatry Program, University of Virginia Health System, Charlottesville, Virginia | Consultant: NOW Coalition for Bipolar Disorder. Research Support: Otsuka, Shire, Pfizer, Lilly, Forest, Merck
- Marcia Verduin, M.D. Professor of Psychiatry and Associate Dean for Students, College of Medicine, University of Central Florida, Orlando, Florida | Scientific Advisory Board: Lake Nona Life Project, a collaborative community research effort sponsored bythe Lake Nona Institute and Johnson & Johnson.
Disclosure of Unapproved or Investigational Use of a Product: FOCUS questions may contain information on off-label uses of particular medications. Off-label use of medications by individual physicians is permitted and common. Decisions about off-label use can beguided by the evidence provided in scientific literature, and clinical experience.
For PC users, we recommend using a computer that is running the most recent version of Microsoft Windows.
For Macintosh users, we recommend using a computer that is running OS X or later.
Although the presentations and website can be viewed on any browser, we suggest Google Chrome for PC users and the latest version of Firefox for Macintosh users. Make sure your computer's software and browsers are updated regularly for an optimal experience.
Due to the media-rich content, we recommend viewing programs at a minimum screen resolution of 800 x 600 pixels, but preferably 1024 x 768 pixels.
Contact firstname.lastname@example.org for questions about this course | Contact email@example.com for technical assistance